|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/395 | |
| C07K 16/22 |
| (11) | Patento numeris | 3427752 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18188992.4 |
| Europos patento paraiškos padavimo data | 2011-07-11 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-01-16 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-04-28 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 36411210 P | 2010-07-14 | US |
| (72) |
WALSH, Scott, US
POTOCKY, Terra, US
DIX, Daniel, US
SIVENDRAN, Renuka, US
|
| (73) |
Regeneron Pharmaceuticals, Inc.,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (54) | STABILIZED FORMULATIONS CONTAINING ANTI-NGF ANTIBODIES |
| STABILIZED FORMULATIONS CONTAINING ANTI-NGF ANTIBODIES |